Skip to main content
. Author manuscript; available in PMC: 2018 Mar 15.
Published in final edited form as: Alzheimers Dement. 2006 Oct;2(4):263–271. doi: 10.1016/j.jalz.2006.07.001

Figure 2.

Figure 2

Graph, showing the anticipated effects of a disease-modifying agent on the course of Alzheimer’s disease in a parallel group design (MMSE = Mini Mental State Examination).